Post
Fighting transplant rejection should be a shared mission.
By joining our equity crowdfunding, your investment will accelerate the development and validation of clinical decision support tools designed to reduce transplant rejection.
Lidio Meireles, PhD·Founder & CEO, Immunomatics·1 min read

By joining our equity crowdfunding, your investment will accelerate the development and validation of clinical decision support tools designed to reduce transplant rejection.
Click to learn more:
wefunder.com/immunomatics